Print Page   |   Contact Us   |   Sign In   |   Join
The Drug Development Process - From Discovery to Commercialization™
Tell a Friend About This EventTell a Friend
 

Included in the course content is an overview of the regulatory and pre-marketing steps that occur to ensure a successful launch. The course also covers sales planning and the commercialization decisions that affect the development of the drug.

5/4/2015 to 5/6/2015
When: May 4-6, 2015
Where: Desmond Hotel and Conference Center
Malvern, Pennsylvania 
United States
Presenter: The Center for Professional Innovation and Innovation
Contact: 855.752.9320

« Go to Upcoming Event List  

 

  

 

The Drug Development Process - From Discovery to Commercialization™

The drug development process involves a series of lengthy steps that determine the degree of success for every drug brought to the market. Decisions made throughout the process affect every aspect of future development and impact heavily on commercialization strategies.

Included in the course content is an overview of the regulatory and pre-marketing steps that occur to ensure a successful launch. The course also covers sales planning and the commercialization decisions that affect the development of the drug.

Topics include:

  • Basic concepts of drug discovery and testing
  • Scientific, regulatory, and management framework for modern pharmaceutical development
  • Pre-clinical study requirements and how information gathered is used for human clinical studies
  • The four major clinical phases (1-4) in the drug development process and the rationale for each and an introduction to the special problems of each phase
  • The economics of drug development
  • Cost/benefit issues in clinical development
  • Discovery and development milestones
  • The IND Process
  • The NDA Process
  • FDA Interactions – Application review and approval process
  • Patents and exclusivity
  • The rationale of government regulations and how they effect the development process
  • The relationship between the Code of Federal Regulations and ICH GCP
  • Designing optimal clinical trials
  • Drug labeling, marketing, and pharmacoeconomic studies
  • Project management cross functional teams during the development process

This course has been pre-approved by the Regulatory Affairs Professionals Society (RAPS) as eligible for 12 credits towards a participant's RAC re-certification upon full completion.

 

Learn more about the course and register.

 

CfPIE is a preferred provider and offers MichBio members a 15% discount on course registration fees. Click here for more information.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal